| ALK |
|
| Cat. No. |
Product |
Activity |
| 5310 |
ASP 3026 |
Potent
anaplastic lymphoma kinase (ALK) inhibitor; also potent ACK inhibitor |
| 6905 |
Ceritinib |
Highly potent ALK inhibitor; also potently inhibits IR, IGF1R,
STK22D and FLT3 |
| 4368 |
Crizotinib |
Potent c-MET/ALK inhibitor |
| 5111 |
GSK 1838705 |
Potent ALK inhibitor; also IR and IGF1R inhibitor |
| 5098 |
KRCA 0008 |
Potent Ack1 and ALK dual inhibitor; orally bioavailable |
| 1614 |
SB 431542 |
Potent, selective inhibitor of TGF-βRI, ALK4 and ALK7 |
| 3263 |
SB 505124 |
Selective inhibitor of TGF-βRI, ALK4 and ALK7 |
|
|
|
| EGFR |
|
| Cat. No. |
Product |
Activity |
| 5318 |
AEE 788 |
Potent EGFR
and VEGFR inhibitor |
| 6812 |
Afatinib
dimaleate |
Potent dual specificity EGFR/HER2 inhibitor; active in vivo |
| 1276 |
AG
1478 hydrochloride |
Highly potent EGFR-kinase inhibitor |
| 414 |
AG 490 |
EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor |
| 1555 |
AG 825 |
Selective ErbB2 inhibitor |
| 2416 |
BIBX
1382 dihydrochloride |
Highly selective EGFR-kinase inhibitor |
| 5022 |
BMS
599626 dihydrochloride |
Potent, selective EGFR and ErbB2 inhibitor |
| 5916 |
Canertinib
dihydrochloride |
Potent EGFR kinase inhibitor |
| 3360 |
CGP 52411 |
EGFR inhibitor. Also inhibits Aβ42 fibril formation |
| 6231 |
Dacomitinib |
Potent irreversible pan ErbB inhibitor |
| 4502 |
DIM |
Inhibits EGFR activation; also induces apoptosis |
| 7424 |
EMI 48 |
Inhibitor of EGFR mutants |
| 7194 |
Erlotinib
Hydrochloride |
Potent, reversible EGFR tyrosine kinase inhibitor |
| 1110 |
Genistein |
EGFR kinase inhibitor. Also estrogen and PPARγ ligand |
| 2239 |
GW
583340 dihydrochloride |
Potent dual EGFR/ErbB2 inhibitor; orally active |
| 3580 |
HKI 357 |
Dual irreversible inhibitor of ErbB2 and EGFR |
| 3000 |
Iressa |
Orally active, selective EGFR inhibitor |
| 6962 |
JBJ-03-142-02 |
Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and
mutated receptors |
| 3352 |
JNJ
28871063 hydrochloride |
Potent ErbB receptor family inhibitor |
| 6811 |
Lapatinib |
Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor |
| 1331 |
Lavendustin
A |
EGFR, p60c-src inhibitor |
| 7371 |
Neratinib |
Potent HER2 receptor tyrosine kinase and EGFR kinase inhibitor |
| 1037 |
PD
153035 hydrochloride |
EGFR-kinase inhibitor |
| 2615 |
PD 158780 |
Potent ErbB receptor family inhibitor |
| 6349 |
Pelitinib |
Potent and irreversible EGFR inhibitor; orally bioavailable |
| 4941 |
PKI
166 hydrochloride |
Potent EGFR-kinase inhibitor |
| 2794 |
PP 3 |
EGFR-kinase inhibitor. Also Src kinase negative control |
| 3599 |
TAK 165 |
Potent and selective ErbB2 inhibitor |
| 3115 |
WHI-P 154 |
Potent EGFR inhibitor. Also inhibits JAK3 |
|
|
|
| Eph Receptors |
|
| Cat. No. |
Product |
Activity |
| 5290 |
KYL |
EphA4 kinase
inhibitor; neuroprotective |
|
|
|
| FGFR |
|
| Cat. No. |
Product |
Activity |
| 4274 |
AP 24534 |
Potent
multi-kinase and pan-Bcr-Abl inhibitor |
| 7454 |
Cediranib |
Potent inhibitor of VEGFR, PDGFR and FGFR |
| 4002 |
FIIN
1 hydrochloride |
Potent, irreversible FGFR inhibitor |
| 7049 |
Nintedanib |
Potent VEGFR, PDGFR and FGFR inhibitor |
| 3724 |
PD 161570 |
Selective FGFR inhibitor |
| 3785 |
PD
166285 dihydrochloride |
FGFR, PDGFRβ and Src inhibitor; also inhibits Wee1 |
| 3044 |
PD 173074 |
FGFR1 and -3 inhibitor |
| 3300 |
SU 5402 |
Potent FGFR and VEGFR inhibitor |
| 3335 |
SU 6668 |
FGFR, VEGFR and PDGFR inhibitor |
|
|
|
| FMS-like receptor
tyrosine kinase-3 (FLT3) |
| Cat. No. |
Product |
Activity |
| 5013 |
AC 710 |
Potent FLT3
inhibitor; also inhibits other PDGFR family members |
| 6905 |
Ceritinib |
Potent FLT3 inhibitor; also potently inhibits ALK, IR, IGF1R and
STK22D |
| 6056 |
GSK 1363089 |
Potent FLT3 inhibtor; also inhibits of MET, VEGFR2, Ron and AXL |
| 5260 |
KG 5 |
PDGFRβ, B-Raf, c-Raf, FLT3 and KIT inhibitor; antiangiogenic |
| 3395 |
Lestaurtinib |
FLT3, JAK2 and TrkA inhibitor; also inhibits AurA and AurB |
| 6788 |
Quizartinib |
Highly potent FLT3 inhibitor |
| 6814 |
Sorafenib |
Flt-3 inhibitor; also inhibits Raf-1, VEGFR-2, VEGFR-3, PDGFR-β
and cKIT |
| 3037 |
SU 5416 |
Inhbitor of VEGFR, KIT, RET, MET and FLT3 |
| 2591 |
TCS 359 |
Potent FLT3 inhibitor |
| 5422 |
XL 184 |
Potent FLT3 inhibitor; also inhibits other RTKs |
|
|
|
| Insulin and
Insulin-like Receptors |
|
| Cat. No. |
Product |
Activity |
| 4774 |
BMS 536924 |
Dual IR/IGF1R
inhibitor |
| 6905 |
Ceritinib |
Potent IR and IGF1R inhibitor; also potently inhibits ALK,
STK22D and FLT3 |
| 1819 |
Demethylasterriquinone
B1 |
Selective insulin RTK activator |
| 5111 |
GSK 1838705 |
Potent IR and IGF1R inhibitor; also inhibits anaplastic lymphoma
kinase (ALK) |
| 3435 |
Insulin
(human) recombinant |
expressed in yeast |
| 5247 |
NVP ADW 742 |
ATP-competitive inhibitor of IGF1R |
| 2956 |
Picropodophyllotoxin |
Selective IGF1R inhibitor |
| 2768 |
PQ 401 |
IGF1R inhibitor |
|
|
|
| MET Receptor |
|
| Cat. No. |
Product |
Activity |
| 4368 |
Crizotinib |
Potent
c-MET/ALK inhibitor |
| 6056 |
GSK 1363089 |
Potent inhibitor of MET, VEGFR2, Ron and AXL |
| 1683 |
K 252a |
Receptor tyrosine kinase inhibitor, inhibits MET |
| 4239 |
PF
04217903 mesylate |
Highly selective MET inhibitor |
| 2693 |
PHA 665752 |
Potent and selective MET inhibitor |
| 5356 |
SGX 523 |
Selective and potent c-MET kinase inhibitor |
| 3037 |
SU 5416 |
MET inhibitor. Also inhibits KIT, RET, VEGFR and FLT3 |
| 5422 |
XL 184 |
Potent c-MET inhibitor; also inhibits other RTKs |
|
|
|
| PDGFR |
|
| Cat. No. |
Product |
Activity |
| 5013 |
AC 710 |
Potent and
selective PDGFR family inhibitor |
| 4274 |
AP 24534 |
Potent multi-kinase and pan-Bcr-Abl inhibitor |
| 7454 |
Cediranib |
Potent inhibitor of VEGFR, PDGFR and FGFR |
| 5993 |
CP 673451 |
Potent and selective PDGFR inhibitor |
| 1222 |
DMPQ
dihydrochloride |
Potent, selective inhibitor of PDGFRβ |
| 6056 |
GSK 1363089 |
Potent PDGFR inhibtor; also inhibits of MET, VEGFR2, Ron and AXL |
| 5906 |
Imatinib
mesylate |
PDGFR inhibitor; also inhibits v-Abl tyrosine kinase and c-kit |
| 6976 |
JNJ
10198409 |
Potent PDGFRα and PDGFRβ inhbitor; also inhibits c-Abl, Lck,
c-Src and Fyn kinases |
| 5260 |
KG 5 |
PDGFRβ, B-Raf, c-Raf, FLT3 and KIT inhibitor; antiangiogenic |
| 7049 |
Nintedanib |
Potent VEGFR, PDGFR and FGFR inhibitor |
| 3785 |
PD
166285 dihydrochloride |
PDGFRβ, FGFR and Src inhibitor; also inhibits Wee1 |
| 6814 |
Sorafenib |
PDGFR-β inhibitor; also inhibits Raf-1, VEGFR-2, VEGFR-3, Flt-3
and cKIT |
| 3304 |
SU 16f |
Potent and selective PDGFRβ inhibitor |
| 3335 |
SU 6668 |
PDGFR, VEGFR and FGFR inhibitor |
| 3768 |
Sunitinib
malate |
Potent VEGFR, PDGFRβ and KIT inhibitor |
|
|
|
| Trk Receptors |
|
| Cat. No. |
Product |
Activity |
| 3826 |
7,8-Dihydroxyflavone |
TrkB agonist |
| 4456 |
Amitriptyline
hydrochloride |
TrkA/B agonist; also a serotonin and noradrenaline uptake
inhibitor |
| 4781 |
ANA 12 |
TrkB receptor antagonist |
| 2837 |
BDNF
(human) |
Activates TrkB and p75 receptors |
| 5062 |
Cyclotraxin
B |
TrkB receptor antagonist |
| 1819 |
Demethylasterriquinone
B1 |
Trk receptor activator; also selective insulin RTK activator |
| 4559 |
GNF 5837 |
Potent Trk inhibitor; inhibits TrkA, TrkB and TrkC |
| 2238 |
GW 441756 |
Potent, selective TrkA inhibitor |
| 5961 |
HIOC |
Selective TrkB receptor agonist; neuroprotectant |
| 3395 |
Lestaurtinib |
TrkA, JAK2 and FLT3 inhibitor; also inhibits AurA and AurB |
| 4607 |
LM 22A4 |
Potent TrkB agonist |
| 6037 |
LM22B 10 |
TrkB and TrkC agonist; brain penetrant |
| 6115 |
PF 06273340 |
Potent and selective pan-Trk inhibitor; peripherally restricted |
|
|
|
| VEGFR |
| Cat. No. |
Product |
Activity |
| 5318 |
AEE 788 |
Potent VEGFR
and EGFR inhibitor |
| 4274 |
AP 24534 |
Potent multi-kinase and pan-Bcr-Abl inhibitor |
| 4350 |
Axitinib |
Potent VEGFR-1, -2 and -3 inhibitor |
| 6069 |
BMS 605541 |
Potent VEGFR-2 inhibitor |
| 7454 |
Cediranib |
Potent inhibitor of VEGFR, PDGFR and FGFR |
| 6056 |
GSK 1363089 |
Potent inhibitor of MET, VEGFR2, Ron and AXL |
| 2542 |
Ki 8751 |
Potent, selective VEGFR-2 inhibitor |
| 7049 |
Nintedanib |
Potent VEGFR, PDGFR and FGFR inhibitor |
| 6015 |
RAF 265 |
VEGFR-2 and Raf kinase inhibitor |
| 6814 |
Sorafenib |
VEGFR-2 and VEGFR-3 inhibitor; also inhibits Raf-1, PDGFR-β,
Flt-3 and cKIT |
| 3300 |
SU 5402 |
Potent VEGFR and FGFR inhibitor |
| 3037 |
SU 5416 |
VEGFR inhibitor. Also inhibits KIT, RET, MET and FLT3 |
| 3335 |
SU 6668 |
VEGFR, PDGFR and FGFR inhibitor |
| 3768 |
Sunitinib
malate |
Potent VEGFR, PDGFRβ and KIT inhibitor |
| 5680 |
Vatalanib
succinate |
Potent VEGFR inhibitor; also aromatase inhibitor |
| 5422 |
XL 184 |
Potent VEGFR inhibitor; also inhibits other RTKs |
| 2475 |
ZM
323881 hydrochloride |
Potent, selective inhibitor of VEGFR-2 |